source · text/markdown
source_aaa162cb59a94f70
sha256 2969115e72f68f1dc77e066ed3a33d554fa13bb8b02d0ac49399f814fe5a7137
by researka:v2 · 2026-07-02 03:41:37.395543+04:00
# Alpha memo: One Bout of Resistance Training Does Not Enhance Metformin Actions in Prediabetic and Diabetic Individuals Hypothesis-level alpha signal; not clinical advice. **Alpha hypothesis:** metformin resistance training may be hiding a metformin / diabetic / not boundary condition: training modulate humoral inflammatory and one bout training does point in different directions. **Signal score:** `100` (novelty `58`, evidence `100`) **Evidence bridge:** metformin, diabetic, not, resistance. **Tension:** null, positive. **Evidence graph:** - 10.1249/MSS.0000000000002889 - primary (strongest direct human evidence) - 10.1111/acel.13039 - mechanism (mechanism context for evidence graph) - 10.17632/w8rt2r7vx3 - replication (replication context for evidence graph) - 10.3389/fphys.2022.872745 - consensus (consensus context for evidence graph) - 10.1249/01.mss.0000764428.80520.ab - boundary (boundary context for evidence graph) **Receipt roles:** - 10.1249/MSS.0000000000002889 - null_signal (direct human reversal) **Claim ledger:** - 10.1249/MSS.0000000000002889 - null_signal; design=randomized_trial; population=human; outcome=long; direction=null; support=direct/high - 10.1111/acel.13039 - mechanism; design=randomized_trial; population=human; outcome=hypertrophy; direction=negative/null/positive; support=direct/high - 10.17632/w8rt2r7vx3 - replication; design=intervention_study; population=human; outcome=unspecified; direction=negative/positive; support=direct/high - 10.3389/fphys.2022.872745 - consensus; design=randomized_trial; population=human; outcome=hypertrophy; direction=negative/null/positive; support=direct/high - 10.1249/01.mss.0000764428.80520.ab - boundary; design=randomized_trial; population=human; outcome=chronic; direction=null; support=indirect/medium **Why it matters:** This is a receipt-bound lead for investigation: two independent search hits share a non-obvious bridge term, so the memo can test whether that bridge explains a boundary condition or a new angle. **What would falsify it:** A follow-up search fails to find direct receipts where the bridge term and both evidence streams appear in the same source-grounded claim, or the apparent connection collapses to one duplicated source. **Receipts:** 1. 10.1249/MSS.0000000000002889 One Bout of Resistance Training Does Not Enhance Metformin Actions in Prediabetic and Diabetic Individuals, 2022, Medicine & Science in Sports & Exercise. Source: fullraw:semantic_scholar. ID: https://doi.org/10.1249/MSS.0000000000002889 2. 10.1111/acel.13039 Metformin blunts muscle hypertrophy in response to progressive resistance exercise training in older adults: A randomized, double‐blind, placebo‐controlled, multicenter trial: The MASTERS trial, 2019, Aging Cell. Source: fullraw:semantic_scholar. ID: https://doi.org/10.1111/acel.13039 3. 10.17632/w8rt2r7vx3 Effect of resistance training versus metformin intervention on non-obese patients with polycystic ovary syndrome, 2024. Source: fullraw:openalex. ID: https://doi.org/10.17632/w8rt2r7vx3 4. 10.3389/fphys.2022.872745 Potential Benefits of Combined Statin and Metformin Therapy on Resistance Training Response in Older Individuals, 2022, Frontiers in Physiology. Source: fullraw:semantic_scholar. ID: https://doi.org/10.3389/fphys.2022.872745 5. 10.1249/01.mss.0000764428.80520.ab One Bout Of Resistance Exercise Does Not Interfere With Metformin Antidiabetic Actions In Individuals With Metabolic Syndrome, 2021. Source: fullraw:openalex. ID: https://doi.org/10.1249/01.mss.0000764428.80520.ab **Safety note:** This memo is an alpha hypothesis. A later LLM writer may sharpen prose, but it may not add claims beyond the receipts above.
metadata
{
"article_type": "alpha_memo",
"domain_slug": "longevity_research",
"researka_object_type": "submission",
"researka_submission_id": "c6dd5bba-e9fe-4b34-bbe2-25db5d76fe7a",
"title": "One Bout of Resistance Training Does Not Enhance Metformin Actions in Prediabetic and Diabetic Individuals"
}